Thomas Dayspring, MD, FACP, FNLA, NCMP
Dr. Thomas Dayspring is a Diplomate of both the American Board of Internal Medicine and American Board of Clinical Lipidology. He is also a Fellow of both the American College of Physicians (FACP), and the National Lipid Association (FNLA). He is a certified menopause practitioner by the North American Menopause Society (NCMP) and a Clinical Assistant Professor of Medicine at the University of Medicine and Dentistry of New Jersey - New Jersey Medical School. Until 2012 when he became the director of cardiovascular education at the Foundation for Health Improvement and Technology in Richmond, VA he had been in private medical practice for 37 years in northern New Jersey, the last decade of which was limited to consulting patients with complex lipid disorders and or atherosclerotic heart disease.
He is listed in the Guide to America’s Top Physicians and is a faculty member of the Masters of Lipidology Course offered by the National Lipid Association (NLA) and on the Editorial Board of the Journal of Clinical Lipidology. He was awarded the NLA’s President's Service Award in 2011 for his contributions to clinical lipidology.
He is one of the most requested educators in the United States with expertise on atherothrombosis, lipoprotein and vascular biology, advanced lipoprotein testing, sterol biology and the CV effects of estrogen and selective estrogen receptor modulation. Dr. Dayspring has given over 4000 lectures in all 50 states, including over 500 CME programs at hospital and medical school grand rounds, and has participated as faculty in multiple other educational venues such as teleconferences and web casts during the last fourteen years.
He is the author of several textbook chapters and peer-reviewed articles, CME publications relating to lipids (including strerols) and lipoproteins including their pharmacologic modulation and their relationship to gender, estrogen and raloxifene. He also authors “Lipidaholics Anonymous” a newsletter received by several thousand healthcare professionals. He is a Power Point expert and has created multiple animated slides, including CME CDs, relating to all aspects of lipidology and atherosclerosis many of which are now featured on LecturePad at www.fhit.org.
Tara Dall, MD
Tara Dall, MD graduated in the first class of Diplomates of the American Board of Clinical Lipidology and is President-Elect of the Midwest Lipid Association; her clinic has been nationally recognized as the first fully certified Level II lipid clinic in the United States. She is also one of a handful of United States physicians treating pediatric dyslipidemia. She attended University of Wisconsin-Madison for undergraduate, medical school training, and family medicine residency.
Entering private practice in 2001, she formed the Cholesterol & Lifestyle Center in 2006 with the goal of aggressive detection and treatment of atherosclerotic cardiovascular disease. In 2008 she formed Advanced Lipidology, Early Detection Center for Heart Disease and Diabetes. She has a special interest in advanced lipid testing and CIMT technology, women’s heart disease, polycystic ovarian syndrome, and pediatric obesity. A published author in the field of lipidology, she has also been involved in CIMT research in collaboration with University of Wisconsin-Madison. In 2010, she co-founded Lecturepad.org with Bajet Nour, MD, with the hopes of advancing clinical understanding and application of advanced lipid testing.
Because of her passion and expertise, Dr. Dall has been invited to lecture both nationally and internationally in every venue from hospital and medical school grand rounds to large-scale community events. She also has appeared on CNN Radio, Milwaukee’s FOX News, WISN-TV, WTMJ-TV, Reach MD Satellite Radio, RadioHealth Journal and has been a keynote speaker for the American Heart Association GO RED for women community events.
Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA
Keith C. Ferdinand, MD, is a clinical cardiologist and was previously the Medical Director of Heartbeats Life Center, and Professor of Clinical Pharmacology at Xavier University College of Pharmacy in New Orleans. In the community, Dr. Ferdinand was the principal investigator, and present board member, of the Healthy Heart Community Prevention Project, a cardiovascular risk program targeting African American and other high-risk populations. Healthy Heart is a nationally recognized model for community-based health outreach and intervention. He was host and producer of “Health Issues 2000,” a community cable talk show, and previously produced “You and Your Health,” a local radio talk show in New Orleans.
Dr. Ferdinand was a member of the ALLHAT Data Safety and Monitoring Board and chair of Section Four of the Sixth Report of the Joint National Committee. He was a former chair and member of the Ad Hoc Committee on Minority Populations for the National Heart Lung and Blood Institute (NHLBI), and a member of the National High Blood Pressure Education Program Coordinating Committee. He was also director of the NHLBI Physician’s Health Network, a program that educated physicians and the lay population on cardiovascular risk reduction.
He is past president and former member of the Louisiana State Board of Medical Examiners and past president of the Orleans Division of the American Heart Association. He was past chair and Chief Science Officer of the Association of Black Cardiologists, Inc. and was Director of their Hurricane Katrina Relief effort, known as the HOPE (Health Outreach and Empowerment) Initiative.
Dr. Ferdinand received his medical degree from Howard University College of Medicine and completed internal medicine at the LSU Health Sciences Center and cardiology at LSU and Howard University. He is board certified in internal medicine and cardiovascular disease, a diplomat certified in the subspecialty of nuclear cardiology, an American Society of Hypertension certified specialist in clinical hypertension, and a Fellow of the American College of Cardiology, American Heart Association, the National Lipid Association and the American Society of Hypertension.
Dr. Ferdinand is widely published and has written chapters for Cardiology Clinics, Annual of Drug Therapy, and AHA Hypertension Primer, and Cardiovascular Diseases in Blacks. Dr. Ferdinand was Editor-in-Chief of the 2009 Educational Review Manual in Cardiovascular Disease (Castle Connolly). He is co-author of Overcoming Katrina African American Voices from the Crescent City and Beyond (Palgrave McMillan 2009), a collection of 27 oral histories. .He also was co-editor of Cardiovascular Disease in Racial &Ethnic Minorities (Humana Press 2009).
In 2004, Dr. Ferdinand received the Louis B. Russell, Jr. Memorial Award of the American Heart Association and the Walter M. Booker Community Service Award of the Association of Black Cardiologists. In 2010 he was recognized by the Congressional Black Caucus Health Trust with an award for journalism and the Charles Drew award for medical excellence in conjunction with the National Minority Quality Foundation.
Dr. Ferdinand was a Clinical Professor, Cardiology Division Department of Medicine at Emory University of Atlanta, and an Adjunct Clinical Professor, Department of Medicine at the Morehouse School of Medicine also in Atlanta, Georgia before becoming Professor of Clinical Medicine at Tulane University School of Medicine.
He is the present Chair of the National Forum for Heart Disease and Stroke Prevention ,a coalition which provides the leadership and encouragement for collaboration among over 60 organizations.
Peter Howard Jones, MD, FACP, FNLA
Peter Howard Jones, MD, is an Associate Professor in the Department of Medicine, Center for Cardiovascular Disease Prevention at the Baylor College of Medicine. He also serves as co-director of the Lipid Metabolism and Atherosclerosis Clinic, and as the Medical Director for the Weight Management Center in The Methodist Diabetes and Metabolism Institute.
Dr. Jones received his BS in chemistry in 1974 at Washington and Lee University, where he was a summa cum laude and a Phi Beta Kappa student. He completed his MD at the Baylor College of Medicine in 1977 as the Micheal E. DeBakey Scholar. He completed his internal medicine residency at Baylor, and is board certified in internal medicine and clinical lipidology. He is also a Fellow of the American College of Physicians and of the National Lipid Association. He was a board member of the National Lipid Association (NLA) from 2006 -2010, served as the Secretary (2003-2004) and as President (2005-2006) of that organization, and is a board member of the American Board of Clinical Lipidology.
He has served in a number of academic, scientific and community committees and has published more than 170 clinical abstracts, articles, and chapters in textbooks. He is an Associate Editor of the Journal of Clinical Lipidology.
Dr. James A. Underberg, MD, MS, FSVM, FACPM, FACP, FASH, FNLA
Dr. Underberg is a Clinical Assistant Professor of Medicine in the Division of General Internal Medicine at NYU Medical School and the NYU Center for Cardiovascular Disease Prevention .He is the Director of the Bellevue Hospital Primary Care Lipid Management Clinic and is also a member of the executive committee of the Division of General Internal Medicine. His clinical focus is Preventive Cardiovascular Medicine. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension and a Diplomate of the American Board of Clinical Lipidology. Dr. Underberg is a founding member and president-elect of the Board of Directors of the Northeast Chapter of the National Lipid Association. He was also serves on the National Board of the National Lipid Association for the term 2011-2014. He is a member of the editorial board of the Journal of Clinical Lipidology, co-chairs the communication committee of the NLA and is the co-editor of the NLA quarterly newsletter Lipid Spin. Dr. Underberg also serves as the Co-Chair and faculty for the National Lipid Association Lipid Management Training Course and Lipid University. He currently serves on the CME committee of the American Society of Hypertension. He graduated from Yale University with a BS and MS and from the University of Pennsylvania Medical School. His internship and residency were completed at NYU-Bellevue Hospital Medical Center. He has been elected a fellow of the American College of Preventive Medicine, the Society of Vascular Medicine, the National Lipid Association and the American College of Physicians and the American Society of Hypertension. He is currently involved in several clinical trials in the areas of hypertension, lipids, diabetes and cardiovascular disease prevention. He sees patients both in a university based referral practice and in the Bellevue Hospital Lipid Clinic.
John E. West, MD, FAAFP
John E. West, M.D., F. A.A.F.P. is a Diplomate of the American Board of Clinical Lipidology since 2008, Diplomate of the American Board of Family Medicine since 1988, Fellow of the American Academy of Family Physicians, and a member of the National Lipid Association. He has been in solo private practice in Snellville, Ga., a suburb of Atlanta, since 1988. Dr. West is a third generation physician. His grandfather graduated from the Medical College of Virginia in 1900, his father from the Medical College of Georgia in 1955, and Dr. West graduated from the Medical College of Georgia in 1985. The three of them have provided over 112 years of continuous medical service.
Dr. West has received awards of excellence from his peers, his patients, and national organizations. He is honored to serve and he is passionate about teaching medical advances in the fight against the number one killer in the United States. Through the implementation of new technologies, the risk for ASCAD can be identified more accurately. Dr. West is dedicated to the principles of aggressive management of lipoprotein disorders.
William C. Cromwell, MD, FAHA, FNLA, FAAFP
Dr. Cromwell received his doctoral degree in medicine from the Louisiana State University School of Medicine in New Orleans, Louisiana. He completed residency training at the Trover Clinic Foundation in Madisonville, Kentucky were he received one of twenty national Mead Johnson Graduate Fellowships. Subsequently, he completed postgraduate work in Lipid Disorders at the Washington University School of Medicine Lipid Research Center in St. Louis, Missouri.
From 1991 to 1994 Dr. Cromwell served as Head of the Division of Lipid Disorders and Medical Director of The Lipid Treatment Program at the Trover Clinic in Madisonville, Kentucky. He moved to Central Florida in 1994 to begin work with The Florida Lipid Associates serving as Medical Director of The Lipid Consultation Program in Lake Wales, Florida and Medical Director of The Florida Lipid Institute in Orlando, Florida.
Dr. Cromwell continued his work in Florida until October, 1999 when he accepted a joint position as Chief Medical Officer of LipoScience, Inc. (formerly LipoMed, Inc.) and Medical Director of The Lipoprotein and Metabolic Disorders Institute in Raleigh, North Carolina.
Dr. Cromwell maintained these positions from October, 1999 to January, 2005 at which time he accepted the position of Medical Director of the Division of Lipoprotein Disorders at the Presbyterian / Novant Center for Preventive Cardiology in Charlotte, North Carolina. From December, 2008 – November, 2010 Dr. Cromwell served as Chief of the Division of Atherosclerosis and Lipoprotein Disorders for the Presbyterian Cardiovascular Institute, as well as Medical Director of Novant Heart & Wellness in Raleigh, NC. In 2011 Dr. Cromwell transitioned his clinical practice to the Lipoprotein and Metabolic Disorders institute in Raleigh, NC.
Since March, 2000 Dr. Cromwell has served as Adjunct Associate Professor in the Hypertension and Vascular Disease Center at Wake Forest University School of Medicine. Dr. Cromwell is a fellow of the American Heart Association Council on Atherosclerosis, Thrombosis and Vascular Biology, Fellow of the National Lipid Association and Fellow of the American Academy of Family Physicians. Additionally, he is a member of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism, as well as the Southeastern Lipid Association. Dr. Cromwell has authored numerous peer-reviewed articles and book chapters in the fields of lipoprotein disorders and physical chemistry.
Peter Toth, MD received his B.A. in Biochemistry from Princeton University and a Ph.D. in Biochemistry from Michigan State University. He graduated from Wayne State University School of Medicine and completed residency training in Family Medicine at the University of Iowa Hospitals and Clinics. Dr. Toth is a member of the American College of Cardiology Foundation Council on Cardiovascular Disease Prevention and the American Heart Association’s Council on Lipoproteins, Lipid Metabolism, and Thrombosis. He is a member of Alpha Omega Alpha, Sigma Xi.
Dr. Toth has authored and coauthored over two hundred twenty publications in medical and scientific journals and textbooks. He is Editor-in-Chief of the Year in Lipid Disorders (Atlas Publishing, Oxford, UK) and an Associate Editor for the Year Book of Endocrinology (Elsevier, New York). He is coeditor with Antonio Gotto of the textbook, Comprehensive Management of High Risk Cardiovascular Patients (Taylor and Francis, New York) with Michael Davidson of Therapeutic Lipidology (Humana, Philadelphia), with Dominic Sica of Current Controversies in Dyslipidemia Management (Atlas Publishing, Oxford), with Kevin Maki of Practical Lipid Management (Wiley-Blackstone, London), with Christopher Cannon of Comprehensive Cardiovascular Care in the Primary Care Setting(Springer Humana, Philadelphia), Domenic Sica of Clinical Challenges in Hypertension vols I and II (Clinical Publishing, Oxford, UK), Cardiac Lipoglucotoxicity with Vasu Raghavan, and Lipoproteins in Diabetes Mellitus with Alicia Jenkins and Timothy Lyons.. He has lectured on many topics in cardiovascular medicine throughout the world.
SERGIO FAZIO, MD, PhD
Sergio Fazio, MD is a graduate of the medical school of the University of Rome, Italy, Dr. Fazio continued at the same institution with a fellowship in Metabolic Diseases. In 1985, he undertook a Ph.D. program in Experimental Medicine at the University of Siena, Italy, and completed it at the University of California, San Francisco (UCSF). In 1988 Dr. Fazio joined the Gladstone Institute of Cardiovascular Disease, UCSF, as a postdoctoral scientist first, and then as a Staff Scientist (Instructor in Medicine, UCSF).
In 1993 Dr. Fazio joined the faculty of the School of Medicine at Vanderbilt University as an Assistant Professor in the Division of Endocrinology and Diabetes. There, he co-founded the Vanderbilt Lipid Clinic and became Director of the Vanderbilt Lipid Laboratory. He was promoted to the rank of Associate Professor in July 1998. In November of 1999 Dr. Fazio joined the Division of Cardiovascular Medicine to become the co-Director of the Atherosclerosis Research Unit. He was promoted to Professor in November 2002.His clinical interest is the management of dyslipidemic patients. He participates in clinical trials to study the effectiveness and efficacy of lipid-lowering drugs, and is involved in the determination of new mutations causing altered lipid levels in humans.
Dr. Fazio’s NIH-supported research portfolio focuses on the pathogenesis of genetic dyslipidemias, the early cellular events in atherogenesis, and gene therapy approaches to atherosclerosis. He has been an Established Investigator of the American Heart Association and is PI and Co-PI on several NIH grants. He has published over 180 papers, including original articles, reviews, editorials, and book chapters. He has been a charter member of the Study Section Atherosclerosis and Inflammation in Cardiovascular Disease of the NIH-NHLBI from 2006 to 2010. He is member of the American Society for Clinical Investigation and of the Association of American Physicians. He is on the editorial board of Arteriosclerosis, Thrombosis and Vascular Biology, and of Circulation Research, and is an associate editor for the Journal of Clinical Lipidology.